Where to buy crizotinib

Crizotinib is a targeted therapy drug mainly used to treat patients with non-small cell lung cancer (NSCLC) with ALK (anaplastic lymphoma kinase) or ROS1 gene rearrangement. As an effective targeted drug, crizotinib can inhibit the growth of cancer cells and delay the progression of the disease, and has become one of the standard treatment options for patients with this type of cancer.

Crizotinib prevents the proliferation and metastasis of cancer cells by inhibiting the effects of key enzymes such as ALK and ROS1. The drug is typically used in patients with ALK- or ROS1-positive non-small cell lung cancer, especially those whose disease continues to worsen after first-line chemotherapy. The use of crizotinib has greatly improved the quality of life and survival of these patients.

The therapeutic effect of crizotinib has been proven by multiple clinical trials and has become one of the preferred targeted drugs for the treatment of ALK positive non-small cell lung cancer. By targeting the ALK enzyme, it interferes with the signaling pathways of cancer cells, reduces the spread of cancer cells, and improves the overall survival rate of patients.

Crizotinib has been approved and marketed in China and has been included in medical insurance. Patients can purchase the drug through hospital pharmacies or medical insurance channels. The specific price will be affected by medical insurance reimbursement policies and regional differences, but the approximate price is around four to five thousand yuan. Patients should confirm the latest prices and reimbursement policies with their local hospital pharmacy or medical insurance bureau when purchasing.

There are mainly two types of crizotinib available abroad: original drugs and generic drugs. The original drugs produced by Pfizer are more expensive, usually around 10,000 yuan. Generic drugs are more affordable, with versions mainly produced in Bangladesh and Laos priced between one thousand and two thousand yuan. The ingredients of generic drugs and original drugs are basically the same and the therapeutic effects are similar, so patients can choose according to their own needs.

It is worth noting that the price of the generic version of crizotinib in overseas markets is relatively low, and the efficacy and safety of the generic version are almost the same as the original drug, making it an economical choice for some patients to purchase drugs.